Biomarkers in Medicine

Biomarkers in Medicine

BIOMARK MED
影响因子:2.1
是否综述期刊:
是否预警:不在预警名单内
是否OA:
出版国家/地区:ENGLAND
出版社:Future Medicine Ltd.
发刊时间:2007
发刊频率:Bimonthly
收录数据库:SCIE/Scopus收录
ISSN:1752-0363

期刊介绍

Biomarkers are physical, functional or biochemical indicators of physiological or disease processes. These key indicators can provide vital information in determining disease prognosis, in predicting of response to therapies, adverse events and drug interactions, and in establishing baseline risk. The explosion of interest in biomarker research is driving the development of new predictive, diagnostic and prognostic products in modern medical practice, and biomarkers are also playing an increasingly important role in the discovery and development of new drugs. For the full utility of biomarkers to be realized, we require greater understanding of disease mechanisms, and the interplay between disease mechanisms, therapeutic interventions and the proposed biomarkers. However, in attempting to evaluate the pros and cons of biomarkers systematically, we are moving into new, challenging territory.Biomarkers in Medicine (ISSN 1752-0363) is a peer-reviewed, rapid publication journal delivering commentary and analysis on the advances in our understanding of biomarkers and their potential and actual applications in medicine. The journal facilitates translation of our research knowledge into the clinic to increase the effectiveness of medical practice.As the scientific rationale and regulatory acceptance for biomarkers in medicine and in drug development become more fully established, Biomarkers in Medicine provides the platform for all players in this increasingly vital area to communicate and debate all issues relating to the potential utility and applications.Each issue includes a diversity of content to provide rounded coverage for the research professional. Articles include Guest Editorials, Interviews, Reviews, Research Articles, Perspectives, Priority Paper Evaluations, Special Reports, Case Reports, Conference Reports and Company Profiles. Review coverage is divided into themed sections according to area of therapeutic utility with some issues including themed sections on an area of topical interest.Biomarkers in Medicine provides a platform for commentary and debate for all professionals with an interest in the identification of biomarkers, elucidation of their role and formalization and approval of their application in modern medicine. The audience for Biomarkers in Medicine includes academic and industrial researchers, clinicians, pathologists, clinical chemists and regulatory professionals.
生物标志物是生理或疾病过程的物理、功能或生化指标。这些关键指标可为确定疾病预后、预测治疗反应、不良事件和药物相互作用以及建立基线风险提供重要信息。对生物标志物研究兴趣的爆发正在推动现代医疗实践中新的预测、诊断和预后产品的开发,生物标志物在新药的发现和开发中也发挥着越来越重要的作用。为了实现生物标志物的充分利用,我们需要更深入地了解疾病机制,以及疾病机制、治疗干预和拟议生物标志物之间的相互作用。然而,在试图系统地评估生物标志物的利弊时,我们正在进入一个新的、具有挑战性的领域。《生物标志物在医学中》(ISSN 1752-0363)是一本同行评审的、快速出版的期刊,它提供了我们对生物标志物及其在医学中的潜在和实际应用的理解进展的评论和分析。随着医学和药物开发中生物标志物的科学原理和监管接受度越来越全面,生物标志物在临床中的应用也越来越广泛,医学生物标志物为这一日益重要的领域的所有参与者提供了一个平台,以交流和讨论与潜在效用和应用有关的所有问题。每一期都包括各种各样的内容,为研究专业人士提供全面的报道。文章包括客座社论,访谈,评论,研究文章,观点,优先论文评估,特别报告,案例报告,会议报告和公司简介。综述报道根据治疗效用的领域分为主题部分,其中一些问题包括主题部分的主题感兴趣的领域。医学生物标志物为所有专业人士提供了一个评论和辩论的平台,他们对生物标志物的鉴定,阐明其作用,以及其在现代医学中的应用的正式化和批准感兴趣。医学生物标志物的受众包括学术和工业研究人员、临床医生、病理学家、临床化学家和监管专业人士。
年发文量 129
国人发稿量 68.38
国人发文占比 0.53%
自引率 -
平均录取率0
平均审稿周期 较慢,6-12周
版面费 -
偏重研究方向 医学-医学:研究与实验
期刊官网 http://www.futuremedicine.com/loi/bmm
投稿链接 http://www.futuremedicine.com/page/submitarticle

期刊高被引文献

Measurement of pancreatic stone protein in the identification and management of sepsis.
来源期刊:Biomarkers in medicineDOI:10.2217/bmm-2018-0194
Mitochondrial DNA deletions accurately detect endometriosis in symptomatic females of child-bearing age.
来源期刊:Biomarkers in medicineDOI:10.2217/bmm-2018-0419
Long noncoding RNA MALAT1 acts as a potential biomarker in cancer diagnosis and detection: a meta-analysis.
来源期刊:Biomarkers in medicineDOI:10.2217/bmm-2018-0128
NT-proBNP plasma levels as biomarkers for pulmonary hypertension in healthy infants with respiratory syncytial virus infection.
来源期刊:Biomarkers in medicineDOI:10.2217/bmm-2018-0348
CD44 epithelial isoform inversely associates with invasive characteristics of colorectal cancer.
来源期刊:Biomarkers in medicineDOI:10.2217/bmm-2018-0337
Charcot-Leyden crystal protein/galectin-10 is a surrogate biomarker of eosinophilic airway inflammation in asthma.
来源期刊:Biomarkers in medicineDOI:10.2217/bmm-2018-0280
Methylcrotonoyl-CoA carboxylase 2 overexpression predicts an unfavorable prognosis and promotes cell proliferation in breast cancer.
来源期刊:Biomarkers in medicineDOI:10.2217/bmm-2018-0475
ProANP and proBNP in plasma as biomarkers of heart failure.
来源期刊:Biomarkers in medicineDOI:10.2217/bmm-2019-0158
Placenta growth factor and sFlt-1 as biomarkers in ischemic heart disease and heart failure: a review.
来源期刊:Biomarkers in medicineDOI:10.2217/bmm-2018-0492
Altered signature of apoptotic endothelial cell-derived micro vesicles predicts chronic heart failure phenotypes.
来源期刊:Biomarkers in medicineDOI:10.2217/bmm-2018-0449
Elevated SLC6A6 expression drives tumorigenesis and affects clinical outcomes in gastric cancer.
来源期刊:Biomarkers in medicineDOI:10.2217/bmm-2018-0256
The intricate role of miR-155 in carcinogenesis: potential implications for esophageal cancer research.
来源期刊:Biomarkers in medicineDOI:10.2217/bmm-2018-0127
21-gene recurrence score and adjuvant chemotherapy decisions in patients with invasive lobular breast cancer.
来源期刊:Biomarkers in medicineDOI:10.2217/bmm-2018-0396
Galectin-3 is associated with arterial stiffness among hemodialysis patients.
来源期刊:Biomarkers in medicineDOI:10.2217/bmm-2018-0488
Evaluation of neutrophil-lymphocyte ratio in predicting bloodstream infection.
来源期刊:Biomarkers in medicineDOI:10.2217/bmm-2018-0253
The prognostic value of faciogenital dysplasias as biomarkers in head and neck squamous cell carcinoma.
来源期刊:Biomarkers in medicineDOI:10.2217/bmm-2019-0273
The impact of monocyte to high-density lipoprotein ratio on reduced renal function: insights from a large population.
来源期刊:Biomarkers in medicineDOI:10.2217/bmm-2018-0406
Biochemical markers of muscle damage and high serum concentration of creatine kinase in patients on statin therapy.
来源期刊:Biomarkers in medicineDOI:10.2217/bmm-2018-0379
Osteoprotegerin and osteopontin levels, but not gene polymorphisms, predict mortality in cardiovascular diseases.
来源期刊:Biomarkers in medicineDOI:10.2217/bmm-2018-0458
Preoperative CA125 value predicts Glisson capsule involvement in patients with peritoneal carcinomatosis undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
来源期刊:Biomarkers in medicineDOI:10.2217/bmm-2019-0009
Identification of critical pathways and hub genes in TP53 mutation prostate cancer by bioinformatics analysis.
来源期刊:Biomarkers in medicineDOI:10.2217/bmm-2019-0141
The clinical application of purine nucleosides as biomarkers of tissue Ischemia and hypoxia in humans in vivo.
来源期刊:Biomarkers in medicineDOI:10.2217/bmm-2019-0049
External validation of a panel of plasma microRNA biomarkers for lung cancer.
来源期刊:Biomarkers in medicineDOI:10.2217/bmm-2019-0213
Wound exudate CXCL6: a potential biomarker for wound healing of diabetic foot ulcers.
来源期刊:Biomarkers in medicineDOI:10.2217/bmm-2018-0339
An update of urine and blood metabolomics in chronic kidney disease.
来源期刊:Biomarkers in medicineDOI:10.2217/bmm-2019-0008
The research advances of exosomes in esophageal cancer.
来源期刊:Biomarkers in medicineDOI:10.2217/bmm-2018-0314
Plasma S100A4 level and cardiovascular risk in patients with unstable angina pectoris.
来源期刊:Biomarkers in medicineDOI:10.2217/bmm-2019-0137
Association between high Gal-3 serum levels and worsening of renal function in chronic heart failure outpatients.
来源期刊:Biomarkers in medicineDOI:10.2217/bmm-2018-0349
A candidate intronic CYP24A1 gene variant affects the risk of colorectal cancer.
来源期刊:Biomarkers in medicineDOI:10.2217/bmm-2019-0189
Association of monocyte-to-high density lipoprotein-cholesterol ratio with peripheral neuropathy in patients with Type II diabetes mellitus.
来源期刊:Biomarkers in medicineDOI:10.2217/bmm-2018-0451
Forms of diagnostic material as sources of miRNA biomarkers in hepatocellular carcinoma: a preliminary study.
来源期刊:Biomarkers in medicineDOI:10.2217/bmm-2018-0485
Diagnostic value of NKG2D promoter methylation in hepatitis B virus-associated hepatocellular carcinoma.
来源期刊:Biomarkers in medicineDOI:10.2217/bmm-2019-0102
Variations in laboratory parameters in prechronic disease to determine disease occurrence at the molecular level.
来源期刊:Biomarkers in medicineDOI:10.2217/bmm-2018-0291
Biomarkers in diagnosing and treatment of acute heart failure.
来源期刊:Biomarkers in medicineDOI:10.2217/bmm-2019-0134
Progesterone receptor status and tumor grade predict the 21-gene recurrence score of invasive lobular breast cancer.
来源期刊:Biomarkers in medicineDOI:10.2217/bmm-2019-0209
The relationship between CYP7A1 polymorphisms, coronary artery disease & serum lipid markers.
来源期刊:Biomarkers in medicineDOI:10.2217/bmm-2018-0462
Potential biomarkers for antidiastole of tuberculous and malignant pleural effusion by proteome analysis.
来源期刊:Biomarkers in medicineDOI:10.2217/bmm-2018-0200
Diagnostic and prognostic impact of circulating microRNA-208b and microRNA-499 in patients with acute coronary syndrome.
来源期刊:Biomarkers in medicineDOI:10.2217/bmm-2019-0257
KRAS SNPs are related to colorectal cancer susceptibility and survival in Chinese people.
来源期刊:Biomarkers in medicineDOI:10.2217/bmm-2019-0172
Prognostic value of spot testing urine pH as a novel marker in patients with ST-segment elevation myocardial infarction.
来源期刊:Biomarkers in medicineDOI:10.2217/bmm-2019-0004
Reproducibility of endothelial microparticles in children and adolescents.
来源期刊:Biomarkers in medicineDOI:10.2217/bmm-2019-0229
Plasma C-MYC level manifesting as an indicator in progression of breast cancer.
来源期刊:Biomarkers in medicineDOI:10.2217/bmm-2019-0073
Pharmacodynamic monitoring using biomarkers to individualize pharmacotherapy.
来源期刊:Biomarkers in medicineDOI:10.2217/bmm-2018-0355
A novel 8.7-kb mitochondrial genome deletion accurately detects endometriosis in the plasma of symptomatic women.
来源期刊:Biomarkers in medicineDOI:10.2217/bmm-2019-0451
Prognostic utility of the combination of pretreatment monocyte-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio in patients with NMIBC after transurethral resection.
来源期刊:Biomarkers in medicineDOI:10.2217/bmm-2019-0398
Prognostic performance of pancreatic stone protein in critically ill patients with sepsis.
来源期刊:Biomarkers in MedicineDOI:10.2217/BMM-2019-0174
A novel nomogram for the differential diagnosis between advanced and early appendicitis in pediatric patients.
来源期刊:Biomarkers in medicineDOI:10.2217/bmm-2019-0036
Differentiating between smokers and nonsmokers using serum cotinine.
来源期刊:Biomarkers in medicineDOI:10.2217/bmm-2019-0027
Stromal cell derived factor-1 and long-term prognosis in acute coronary syndrome.
来源期刊:Biomarkers in medicineDOI:10.2217/bmm-2019-0133

质量指标占比

研究类文章占比 OA被引用占比 撤稿占比 出版后修正文章占比
86.05%9.73%-0.75%

相关指数

影响因子
影响因子
年发文量
自引率
Cite Score

预警情况

查看说明
时间 预警情况
2025年03月发布的2025版不在预警名单中
2024年02月发布的2024版不在预警名单中
2023年01月发布的2023版不在预警名单中
2021年12月发布的2021版不在预警名单中
2020年12月发布的2020版不在预警名单中
*来源:中科院《 国际期刊预警名单》

JCR分区

WOS分区等级:Q3区
版本 按学科 分区
WOS期刊SCI分区
WOS期刊SCI分区
WOS期刊SCI分区是指SCI官方(Web of Science)为每个学科内的期刊按照IF数值排 序,将期刊按照四等分的方法划分的Q1-Q4等级,Q1代表质量最高,即常说的1区期刊。
(2024-2025年最新版)
MEDICINE, RESEARCH & EXPERIMENTAL
Q3

中科院分区

查看说明
版本 大类学科 小类学科 Top期刊 综述期刊
2025年3月最新升级版
医学4区
MEDICINE, RESEARCH & EXPERIMENTAL 医学:研究与实验
4区
2023年12月升级版
医学4区
MEDICINE, RESEARCH & EXPERIMENTAL 医学:研究与实验
4区
2022年12月旧的升级版
医学4区
MEDICINE, RESEARCH & EXPERIMENTAL 医学:研究与实验
4区